^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BPI-452080

    i
    Other names: BPI-452080
    Associations

    News

    Trials
    Company:
    Betta Pharma
    Drug class:
    HIF-2α inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    A Study of BPI-452080 in Subjects With Solid Tumors (clinicaltrials.gov)
    P1, N=87, Not yet recruiting, Betta Pharmaceuticals Co., Ltd.
    New P1 trial
    |
    BPI-452080